I-T Raids Dolo-650 Manufacturer Micro Lab’s Office In Bengaluru

Doctors and owners of medical supply stores were prescribing Dolo-650, an analgesic (pain killer) and antipyretic (fever reducer), to coronavirus patients to alleviate pain and fever, which are common Covid symptoms. At the present, however, the I-T has raided Dolo-650 manufacturer Micro Lab’s office in Bengaluru for fraud.

I T Raids Dolo 650 Manufacturer Micro Lab's Office In Bengaluru

In connection with suspected tax fraud, the Income Tax agency searched the offices of Bengaluru-based pharmaceutical company Micro Labs Ltd on Wednesday, reports the Hindustan Times. Micro Labs Ltd produced the Dolo-650 tablet, which has been frequently used by Covid-19 patients for the past two years.

Officials stated that as part of the investigations, the government is taking a look at financial records, balance sheets, and the company’s commercial distributor networks.

A response to the PTI’s questions on the incident from the company is pending.

They claimed that the company’s promoters’ and distributors’ locations, as well as certain other associated places in other cities, are also covered.

Subscribe to GreatGameIndia

Enter your email address to subscribe to GGI and receive notifications of new posts by email.

According to the company’s website, in addition to doing business abroad, it manufactures and markets pharmaceutical products and APIs (Active Pharmaceutical Ingredients) and has 17 manufacturing facilities nationwide.

Dolo-650, Amlong, Lubrex, Diapride, Vildapride, Olmat, Avas, Tripride, Bactoclav, Tenepride-M, and Arbitel are some of its most important pharmaceutical products.

Doctors and owners of medical supply stores were prescribing Dolo-650, an analgesic (pain killer) and antipyretic (fever reducer), to coronavirus patients to alleviate pain and fever, which are common Covid symptoms.

Dolo-650 is “virtually a household name across the country,” according to the manufacturer.

A news report from February that was included on the firm website stated that “The company has sold 350 crore tablets (of Dolo-650) since the Covid-19 outbreak in 2020, and earned revenues of ₹400 crore in a year.”

Dilip Surana, the company’s CMD, is quoted in the article.

GreatGameIndia is being actively targeted by powerful forces who do not wish us to survive. Your contribution, however small help us keep afloat. We accept voluntary payment for the content available for free on this website via UPI, PayPal and Bitcoin.

Support GreatGameIndia

Leave a Reply